Literature DB >> 4026912

Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiency.

O G Nilsen, T Wessel-Aas, F Walseth.   

Abstract

The single oral dose pharmacokinetics of tiaprofenic acid (Surgam) has been investigated in fasting and non-fasting healthy volunteers (200 and 300 mg) and in fasting patients with severe renal insufficiency (200 mg). A dose independent pharmacokinetics of tiaprofenic acid was shown in fasting healthy volunteers and the following parameters were calculated after administration of 200 mg: tl = 0.53 +/- 0.15 h, tm = 1.28 +/- 0.19 h, cm = 27.1 micrograms/ml, ka = 2.79 +/- 0.93 h-1, lambda 2 = 1.06 +/- 0.14 h-1, t1/2 = 3.0 +/- 0.2 h, AUCl-infinity = 80 +/- 7 mg X h/l, Clt = 43.8 +/- 3.7 ml/min and V beta = 11.1 +/- 0.8 l. A small, but significant positive deviation from linearity was observed with increasing dose for cm and AUCl-infinity in non-fasting healthy volunteers, probably due to a slightly higher bioavailability of the 300 mg formulation in the non-fasting state as compared with the 200 mg formulation. Intake of food decreased cm significantly at both dosage levels from 27.1 to 19.1 micrograms/ml and from 47.9 to 39.1 micrograms/ml for 200 and 300 mg, respectively. The absorption kinetics of tiaprofenic acid was not significantly different in fasting healthy volunteers and in fasting patients with severe renal insufficiency. However, a significant increase in t1/2 and AUCl-infinity to 5.8 +/- 0.9 h and 173 +/- 34 mg X h/l, respectively, and a significant decrease in total body clearance to 25.5 +/- 5.3 ml/min were observed in this category of patients. No correlation was found between creatinine clearance and tiaprofenic acid clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026912

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Pharmacokinetics of tiaprofenic acid in children after a single oral dose.

Authors:  L Bertin; E Rey; G Pons; J L Mathiot; M O Richard; P Chrétien; C Saint-Maurice; C Moran; D Ginisty; G Olive
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Pharmacokinetics of tiaprofenic acid in elderly multimorbid patients.

Authors:  D Platt; H Eicher; W Rieck; D Hilgert
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

5.  Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen.

Authors:  A Le Liboux; M Teule; A Frydman; B Oosterhuis; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 6.  Tenoxicam and renal function.

Authors:  R C Heintz
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 7.  Tiaprofenic acid. A reappraisal of its pharmacological properties and use in the management of rheumatic diseases.

Authors:  G L Plosker; A J Wagstaff
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.